160 related articles for article (PubMed ID: 17463001)
1. Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1.
Kobayashi S; Lee SH; Meng XW; Mott JL; Bronk SF; Werneburg NW; Craig RW; Kaufmann SH; Gores GJ
J Biol Chem; 2007 Jun; 282(25):18407-18417. PubMed ID: 17463001
[TBL] [Abstract][Full Text] [Related]
2. Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.
Meng XW; Lee SH; Dai H; Loegering D; Yu C; Flatten K; Schneider P; Dai NT; Kumar SK; Smith BD; Karp JE; Adjei AA; Kaufmann SH
J Biol Chem; 2007 Oct; 282(41):29831-46. PubMed ID: 17698840
[TBL] [Abstract][Full Text] [Related]
3. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization.
Ding Q; He X; Hsu JM; Xia W; Chen CT; Li LY; Lee DF; Liu JC; Zhong Q; Wang X; Hung MC
Mol Cell Biol; 2007 Jun; 27(11):4006-17. PubMed ID: 17387146
[TBL] [Abstract][Full Text] [Related]
4. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis.
Han J; Goldstein LA; Gastman BR; Rabinowich H
J Biol Chem; 2006 Apr; 281(15):10153-63. PubMed ID: 16478725
[TBL] [Abstract][Full Text] [Related]
5. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.
Weng C; Li Y; Xu D; Shi Y; Tang H
J Biol Chem; 2005 Mar; 280(11):10491-500. PubMed ID: 15637055
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.
Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ
Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637
[TBL] [Abstract][Full Text] [Related]
7. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
8. DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex.
Nakajima W; Sharma K; Lee JY; Maxim NT; Hicks MA; Vu TT; Luu A; Yeudall WA; Tanaka N; Harada H
Oncotarget; 2016 Jun; 7(24):36353-36365. PubMed ID: 27166195
[TBL] [Abstract][Full Text] [Related]
9. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.
Ding Q; He X; Xia W; Hsu JM; Chen CT; Li LY; Lee DF; Yang JY; Xie X; Liu JC; Hung MC
Cancer Res; 2007 May; 67(10):4564-71. PubMed ID: 17495324
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the antiapoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) and the stimulation of its message by gonadotropins in the rat ovary.
Leo CP; Hsu SY; Chun SY; Bae HW; Hsueh AJ
Endocrinology; 1999 Dec; 140(12):5469-77. PubMed ID: 10579309
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.
Zhao Y; Altman BJ; Coloff JL; Herman CE; Jacobs SR; Wieman HL; Wofford JA; Dimascio LN; Ilkayeva O; Kelekar A; Reya T; Rathmell JC
Mol Cell Biol; 2007 Jun; 27(12):4328-39. PubMed ID: 17371841
[TBL] [Abstract][Full Text] [Related]
12. Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer.
Kawakami H; Huang S; Pal K; Dutta SK; Mukhopadhyay D; Sinicrope FA
Mol Cancer Ther; 2016 Dec; 15(12):3015-3027. PubMed ID: 27765849
[TBL] [Abstract][Full Text] [Related]
13. Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics.
Choudhary GS; Tat TT; Misra S; Hill BT; Smith MR; Almasan A; Mazumder S
Oncotarget; 2015 Jul; 6(19):16912-25. PubMed ID: 26219338
[TBL] [Abstract][Full Text] [Related]
14. The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.
Song P; Yang S; Hua H; Zhang H; Kong Q; Wang J; Luo T; Jiang Y
J Biol Chem; 2019 Apr; 294(15):5945-5955. PubMed ID: 30782845
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
[TBL] [Abstract][Full Text] [Related]
16. Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer.
Nifoussi SK; Vrana JA; Domina AM; De Biasio A; Gui J; Gregory MA; Hann SR; Craig RW
PLoS One; 2012; 7(10):e47060. PubMed ID: 23056582
[TBL] [Abstract][Full Text] [Related]
17. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
Salas TR; Reddy SA; Clifford JL; Davis RJ; Kikuchi A; Lippman SM; Menter DG
J Biol Chem; 2003 Oct; 278(42):41338-46. PubMed ID: 12900420
[TBL] [Abstract][Full Text] [Related]
18. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
Rosato RR; Almenara JA; Coe S; Grant S
Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
[TBL] [Abstract][Full Text] [Related]
19. Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1.
Thomas LW; Lam C; Clark RE; White MR; Spiller DG; Moots RJ; Edwards SW
PLoS One; 2012; 7(9):e45088. PubMed ID: 23024798
[TBL] [Abstract][Full Text] [Related]
20. Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells.
Vaculová A; Hofmanová J; Soucek K; Kozubík A
FEBS Lett; 2006 Dec; 580(28-29):6565-9. PubMed ID: 17113582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
